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Cunninghamella elegansAbstract Biotransformation of Furanocoumarins; psoralen (1), bergapten (2), xanthotoxin (3) and
imperatorin (4) was explored by Cunninghamella elegans NRRL 1392, revealing the metabolism of
psoralen (1) and bergapten (2) into bergaptol (5), while xanthotoxin (3) and imperatorin (4) were
converted into xanthotoxol (6). On the other hand unexpected conversion of xanthotoxin (3) into
3,4 dihydroxanthotoxin (7) occurred. The structure of the isolated pure metabolites was established
using physical and spectroscopic techniques including, melting points, IR, 1H NMR, 13C NMR and
mass spectroscopy.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Faculty of Pharmacy, Cairo University.1. Introduction
Furanocoumarins represent a large class of compounds which
are active against herbivores and with wide spread occurrence
in Apiacae and Rutaceae and at least other 13 plant families:
Amaranthaceae, Compositae, Cyperaceae, Dipsacaceae,
Fabaceae, Goodeniaceae, Guttiferae, Moraceae, Pittosporaceae,
Rosaceae, Samydaceae and Solanaceae.1 Furanocoumarins
were reported to be used in the treatment of skin disorders
such as psoriasis and skin depigmentation.2
Microbial transformation studies of Furanocoumarins,
which provide themammalianmetabolic pathway, are scarce.3,4
Conducted biotransformation studies on the biotransformation
of Furanocoumarins isoimperatorin and imperatorin by the use
of Glomerella cingulata give the corresponding reduced acid 6,
7-furano-5-prenyloxy-hydrocoumaric acid and, xanthotoxolin high yields.3Meanwhile, imperatorin treated withAspergillus
ﬂavus in growth media produced metabolites which were eluci-
dated as xanthotoxol, E-trichoclin, Z-trichoclin, E-imperatorin
acid, and Z-imperatorin acid.4 These ﬁndings have renewed the
interest in studying mammalian metabolism of Furanocouma-
rins, using C. elegans NRRL 1392; ANOVA microbial models
of mammalianmetabolism for several xenobiotics.5,6 Themajor
metabolites were isolated by different chromatographic tech-
niques and structurally elucidated by IR, 1H NMR, 13C
NMR and mass spectroscopy.
2. Experimental
2.1. General
General psoralen was obtained from Fluka Chemical Com-
pany Inc., Milwankee, Wi, while imperatorin, xanthotoxin
and bergapten from Cairo Company for pharmaceutical
industry, Egypt. IR spectra were recorded on FTIR – 800
Ipc series, Shimadzu 24 Corporation. 1H and 13C NMR
2 G.I.E.A. Attia et al.spectra were obtained on JEOL JNM-ECA 500 and 125 MHz,
respectively. The chemical shift values were reported as ppm
using tetramethyl-silane (TMS) as an internal standard and
coupling constants are expressed in Hz. Negative mode spray
ionization (ESIMS) mass spectra were obtained on Thermo-
Finnigan mass spectrometer (See Fig. 1).
TLC was performed using silica gel plates F-254 for TLC
(5 · 10 mm), (Sigma Chemical Co.,) and precoated silica gel
plastic sheets, (20 · 20 mm) with ﬂuorescent indicator (E.
Merck). Column chromatography was carried out using ﬂash
silica gel for column (Merck) and Sephadex LH-20 (Pharma-
cia, Sweden).
2.2. Fungal biotransformation protocol
2.2.1. Microorganisms7 and culture conditions and components8
C. elegans was obtained from Northern Regional Research
Laboratories (NRRL, Peoria, Illinois).7 The fermentation
experiments8 were performed using a medium consisting of
10 g dextrose, 10 ml glycerol, 5 g yeast NaCl and 1000 ml dis-
tilled water. The PH was adjusted to 6.0 before sterilization at
121 C for 15 min.
2.2.2. Cultivation of microorganism9
The cultures were initiated to grow from lyophilized state by
adding 1 ml of sterile water to microorganism vials. A few
drops of suspended cells were streaked on Sabouraud-dextrose
plates to check the purity. Pure cultures were maintained on
slants of either potato-dextrose agar or Sabouraud-dextrose
agar. The fresh slants were incubated for few days at room
temperature before storage in a refrigerator at (4 C). Fermen-
tation liquid cultures were initiated by transferring a few drops
of suspended cells or a loopful into 25 ml sterile liquid medium
present in a 125 ml Erlenmeyer ﬂask then placing it on a gyra-
tory shaker operating at 250 rpm and at 27 C. The tempera-
ture was maintained at 27 C.
2.2.3. Transformation7
Stage I was initiated from two-week old slants (under aseptic
conditions) by transferring microbial cells into a 250 ml Erlen-
meyer ﬂask, containing 50 ml of sterile liquid medium and
allowed to grow for 24–72 h at 27 Con a gyratory shaker. Stage
II cultures were obtained by transferring 5 ml of stage culture toO O
1 R1= R2=R3=R4=H
2 R1= R2=R4=H, R3=OCH3
3 R1= R2=R3=H, R4=OCH3
4 R1= R2=R3=H, R4=OCH2CH=C(CH3)2
5 R1= R2=R4=H, R3=OH
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Figure 1 Structures of investigated furanocoumarins and the
resulted metabolites.each of 250 ml ﬂasks containing 50 ml of fresh liquid medium.
Both substrate and organism controls were treated in the same
way. Cultures were allowed to grow for 24 h, before the addition
of the acetonic substrate solution (5 mg/0.25 ml per ﬂask). Sam-
ples (5 ml) of the liquid culture were periodically (1, 3, 5, 7, 10
and 15 days) withdrawn from each culture and extracted succes-
sively with chloroform or ethyl acetate then each extract was
separately evaporated to dryness under reduced pressure and
kept for further analysis. The obtained residues were dissolved
in few drops of a suitable organic solvent and Thin layer chro-
matographer on silica gel G plates (E. Merck, F 254) using sol-
vent systems I: Chloroform: Methanol (9.5: 0.5, v/v), solvent
systems II: Chloroform: Methanol (9: 1, v/v), solvent systems
III: Hexane: ethyl acetate (2: 1, v/v). The plates were dried
and visualized under UV-light before and after spraying with
10% sulfuric acid in methanol or alcoholic KOH.10
2.2.4. Fermentation of psoralen
Fermentation of psoralen (1) with C. elegans. Psoralen (1,
40 mg, 5 mg/0.25 ml acetone per eight 250 ml ﬂask containing
50 ml ferment liquid media) was inoculated into stage II cul-
tures of C. elegans as mentioned previously. After 10 d, the fer-
mentation was stopped, cells were removed by ﬁltration and
the broth was extracted twice with an equal volume of ethyl
acetate. The EtOAc residue (27 mg) was chromatographed
on preparative precoated silica G plastic sheets (E. Merck, F
254), alongside a reference spot of psoralen (1) and bergaptol
(5). Zone No. 4 which corresponded was scraped off the plates,
extracted with ethyl acetate and evaporated. The residue was
recrystallized from ethyl acetate and weighed to give the pure
metabolite (5) as green powder (2 mg, in 5% yield). It showed
a faint green ﬂorescence under UV, black color when sprayed
with 10% sulfuric acid reagent and heated for 10 min to 110 C
with an Rf = 0.73 in solvent system V; m.p. = 286–289 C,
soluble in ethyl acetate and methanol.
2.2.5. Fermentation of bergapten
Fermentation of bergapten (2) by C. elegans. Bergapten (2, 1 g)
dissolved in acetone (25 ml), was equally distributed amongst
50, 500ml ﬂasks containing stage II cultures of C. elegans as
mentioned previously. After 7 days, the fermentation was
stopped and cells were removed by ﬁltration and the broth
was extracted twice with an equal volume of ethyl acetate.
The EtOAc residue (300 mg) was chromatographed on the
top of a silica gel (18.9 g, 25 cm · 1 cm) column. Gradient elu-
tion method was adopted, using hexane, then hexane: ethyl
acetate with increasing amount of ethyl acetate till 75%.
About 60 fractions (5 ml each) were collected and monitored
on precoated silica gel G TLC plates, using solvent system
V. Fractions eluted with hexane: EtOAc (2: 1, v/v) showed
one major spot. Those fractions were pooled and evaporated
under vacuum to give a residue of 82 mg. The residue was dis-
solved in 3 ml ethyl acetate and applied on preparative silica
gel G plates (E. Merck, F 254) alongside with a reference spots
of bergapten (2) using solvent system V. The zone location was
deﬁned after the exposure to UV light and spraying the refer-
ence spots with 10% sulfuric acid in methanol. Zone No. 1 was
scraped off the plates, extracted with ethyl acetate and solvent
was evaporated. The residue was crystallized from ethyl
acetate several times and weighed to give an olive green pow-
der of metabolite (5) 11 mg in a yield of 13.4%.
Biotransformation of furanocoumarins by Cunninghamella elegans 32.2.6. Fermentation of xanthotoxin
Fermentation of xanthotoxin (3) byC. elegans. (3, 1 g) Xantho-
toxin dissolved in acetone (25 ml), was equally distributed
amongst 50, 500 ml ﬂasks containing stage II cultures of C. ele-
gans as mentioned previously. After 7 days, the fermentation
was stopped and the cells were removed by ﬁltration. The fer-
mentation broths were extracted twice with an equal volume
of chloroform and ethyl acetate successively and each solvent
was distilled off under reduced pressure to about 600 mg and
210 mg residue respectively. The chloroformic residue was chro-
matographed on silica gel (24 g, 25 cm L · 1 cm D) column,
using the gradient elutionmethod starting with chloroform then
chloroform: methanol with increasing amount of methanol till
10% methanol. Thirty fractions (10 ml each) were collected
and chromatographed on precoated silica gel G plates using sol-
vent systemNo. I and II. Similar fractions were combined, frac-
tions eluted with chloroform:methanol (9.7: 0.3 v/v) showed the
pure metabolite (7); 3,4-dihydro-xanthotoxin, 60 mg in a yield
of 0.6% as golden yellow feathery crystals in chloroform. It
showed a green ﬂorescence under UV, brown color when
sprayed with KOH and bluish black color when sprayed with
anisaldehyde/sulfuric acid reagent with an Rf value = 0.32
using solvent system I; soluble in chloroform and methanol.
The ethyl acetate residue was chromatographed on silica gel
(sigma) column. Gradient elution method was adopted using
hexane then hexane: ethyl acetate as eluent, which yielded 60
fractions (5 ml each) for bergapten column. Fraction eluted
with hexane: EtOAc (2:1) gave 42 mg of xanthotoxol (6).
The residue was chromatographed on silica gel (24 g,
25 cm L · 1 cm D) column, using gradient elution method
starting with chloroform then chloroform: methanol with
increasing amount of methanol till 10% methanol. Thirty frac-
tions (10 ml each) were collected and chromatographed on pre-
coated silica gel G plates using solvent system Nos. I and II.
Similar fractions were combined, fractions eluted with chloro-
form: methanol (9.7: 0.3 v/v) showed the metabolite (6), 20 mg
in a yield of 0.2%. It showed a faint green ﬂorescence under
UV, black color when sprayed with 10% sulfuric acid reagent
and heated for 10 min to 110 C with an Rf = 0.75 in solvent
system V and soluble in ethyl acetate and methanol.2.2.7. Fermentation of imperatorin
Fermentation of imperatorin (4) by C. elegans. imperatorin (4,
1 g) dissolved in acetone (25 ml), was equally distributed
amongst 50, 500ml ﬂasks containing stage II cultures of C. ele-
gans as mentioned previously. After 7 days, the fermentation
was stopped and cells were removed by ﬁltration and the broth
was extracted twice with an equal volume of ethyl acetate. The
EtOAc residue (200 mg) was dissolved in 5 ml ethyl acetate
and applied on preparative silica gel G plates (E. Merck, F
254) with a reference spot of the extract and the metabolite
(6), the plates were developed in solvent system (V) and zone
location was visualized under UV light and spraying the refer-
ence spots with 10% sulfuric acid in methanol. Zone No. 3 was
scraped off the plates, extracted with ethyl acetate, and evapo-
rated to dryness under vacuum, crystallized from ethyl acetate
several times and weighed to give metabolite (6) (5 mg, in a
yield of 0.04%. It showed a faint green ﬂorescence under
UV, black color when sprayed with 10% sulfuric acid reagent
and heated for 10 min to 110 C with an Rf = 0.75 in solvent
system V and soluble in ethyl acetate and methanol.Psoralen (1) CIMS(m/z): 186 [M+]– m.p. 165–166 C [M]+
m/z 186.0300 – 1H NMR (CDCl3): d 6.38 (1H, d, J= 9.8, Hz,
H-3), 7.46 (1H, brs, H-8), 7.68 (1H, s, H-5), 7.70 (1H, d,
J= 2.0 Hz, H-20), 7.80 (1H, d, J= 9.8, Hz, H-4). 13C NMR
(CDCl3): d 99.8 (C-8)(d), 106.4 (C-30) (d), 114.6 (C-3) (d),
115.4 (C-10)(s), 119.9 (C-5) (d), 124.9 (C-6)(s), 144.1 (C-40)
(d), 146.9 (C-20) (d), 152.0 (C-9) (s), 156.4 (C-7) (s), 161.0 (C-
2) (s). UV kMeOHmax nm (e): 246(22600), 291 (10400), 327
(6400)-IR (KBr) cm1: 1625, 1635, 1577, 1136, 824.
Bergapten (2) CIMS(NH4) (m/z): 234 [M+ NH4]
+ – UV
knmmax 223, 243, 249, 259, 268, 311 –
1H NMR (CDCl3) d: 6.26
(1H, H-3, d, J= 9.8), 8.16 (1H, H-4, d, J= 9.8), 4.26 (3H,
hydrogens of methoxy group attached to C-5, s), 7.16 (1H,
H-8, s), 7.60 (1H, H-20, d, J= 2.5), 7.01 (1H, H-30, d,
J= 2.5) – 13C NMR (CDCl3) d: 160.3 (C-2), 112.6 (C-3),
139.6 (C-4), 149.7 (C-5), 60.4 (C-5 attached methoxy group),
114.0 (C-6), 158.3 (C-7), 94.0 (C-8), 152.7 (C-9), 106.4 (C-
10), 144.9 (C-20), 105.2 (C-30).
Bergaptol (5) ESIMS (m/z): 201[M-1]+, m.p. 286.5–
289.5 C – Proton NMR spectral data (Acetone-d6 +
DMSo-d6) displayed resonance at d 6.17 (1H, H-3, d,
J= 9.9), 8.24 (1H, H-4, d, J= 9.9), 11.09 (H-5, hydroxy pro-
ton), 6.98 (1H, H-8, s), 7.75 (1H, H-20, d, J= 2.4) 7.47 (1H, H-
30, d, J= 2.4). 13C NMR spectral data (Acetone-d6 + DMSo-
d6) displayed resonances at d 160.5 (C-2), 111.0 (C-3), 139.6
(C-4), 148.5 (C-5), 112.8 (C-6), 157.7 (C-7), 90.8 (C-8), 153.4
(C-9), 104.05 (C-10), 144.6 (C-20), 104.9 (C-30). IR (KBr)
cm1: 3300, 1689, 1583, 1251, 825.
Xanthotoxin (3) CIMS (NH4) (m/z): 234 [M+ NH4]
+
– UV knmmax 223, 242, 248, 269, 273, 313 – IR tmax cm
1 3100.
3070, 3050, 1726, 1620, 1602, 1575, 1540, 885 – 1H NMR
(CDCl3): d 6.35 (1H, H-3, d, J= 9.5), 7.75 (1H, H-4, d,
J= 9.5), 7.34 (1H, H-5, s), 4.30 (3H of methoxy group
attached to C-8), 7.67 (1H, H-20, d, J= 2.4), 6.8 (1H, H-30,
d, J= 2.4) – 13H NMR (CDCl3): d: 160.7 (C-2), 114.8 (C-3),
144.4 (C-4), 112.9 (C-5), 126.3 (C-6), 147.7 (C-7), 132.6 (C-
8), 61.2 (C-8) (attached methoxy group), 143.9 (C-9), 116.5
(C-10), 146.7 (C-20), 105.2 (C-30).
Xanthotoxol (6) ESIMS (m/z): 201[M-1]+, m.p.243–244 C
– IR tmax cm
1 3070, 3050, 1726, 1620, 1602, 1575, 1540, 885 –
1H NMR spectral data (Acetone-d6) displayed resonance at d
6.3 (1H, H-3, d, J= 9.4), 8.0 (1H, H-4, d, J= 9.4), 7.4 (1H,
H-20, d, J= 2.3), 6.95 (1H, H-30, d, J= 2.3). 13C NMR spec-
tral data (Acetone-d6) displayed resonance at d 159.6 (C-2),
114.7 (C-3), 145.41 (C-4), 110.3 (C-5), 125.7 (C-6), 147.21
(C-7), 130.2 (C-8), 139.81 (C-9), 116.4 (C-10,145.03 (C-20),
106.87 (C-30).
3,4-Dihydroxanthotoxin (7) ESIMS (m/z): 217 [M-1]+
– m.p. 109–110 C – IR tmax cm1 3100, 3070, 3050, 1726,
1620, 1602, 1540, 885 – 1H NMR (CDCl3): d 2.74 (1H, H-3,
t), 3–0367 (1H, H, 4, t), 7.0176 (1H, H-5, S), 4.2 (3H, methoxy
group attached to C-8), 7.48 (1H, H-20, d, J= 1.55), 6.6 (1H,
H-30, d, J= 1.5) – 13C NMR (CDCl3): d 179.7 (C-2), 25.9 (C-
3), 34.2 (C-4), 114.7 (C-5), 123.1 (C-6), 144.4 (C-7), 131.6 (C-
8), 60.7 (C-8 methoxy group), 142.8 (C-9), 121.7 (C-10),
143.9 (C-20), 106.7 (C-30).
Imperatorin (4) CIMS (m/z): 269.08 [M-1]+, m.p. 97.5–
99 C. 1H NMR (CDCl3): d 1.72 (3H, s), 1.74 (3H, s), 5.01
(2H, d, J= 7.3 Hz), 5.61 (1H, t, like, J= 7.3 Hz), 6.37 (1H,
d, J= 9.3 Hz, H-3), 6.81 (1H, d, J= 2.4 Hz, H-30), 7.36 (1H,
s, H-5), 7.69 (1H, d, J= 2.4 Hz, H-20), 7.76 (1H, d,
J= 9.3 Hz, H-4). 13C NMR (CDCl3): d 18.1 (q), 25.8(q),
4 G.I.E.A. Attia et al.70.2(t), 106.7(d), 113.1(d), 114.7(d), 116.1(s), 119.8(d), 125.9(s),
131.7(s), 139.8(s), 143.9(s), 146.6(d), 148.6(s), 160.6(s), 144.3(d).
3. Results and discussion
In the recent study C. elegans converted psoralen (1) into the
metabolite (5). Results of IR studies were in coincidence with
those of standard psoralen11 (see experimental), it displayed
a molecular ion peak at m/z 201 in negative ESI mass spectral
[M-1]+, and showed melting point 286.5–289.5 C.12 These
ﬁndings suggested the hydroxylation of psoralen (1) to obtain
bergaptol (5).
The metabolism of bergapten (2)13 and xanthotoxin (3)13
revealed two metabolites (5&6). Studying the 1H NMR spectra
(see experimental) of these metabolites revealed the disappear-
ance of the methyl group signal at C-8 or C-5 of xanthotoxin
(3)13 and Bergapten (2),13 resonating at dH 4.30–4.26 ppm and
the presence of another singlet signal of C-OH at dH 9.47 ppm
and dH 11.09 ppm, respectively (D2O exchange experiment)
.The signals of carbon atoms of the metabolites (6) and (5)
in the 13C NMR spectra (see experimental) conﬁrmed the
demethylation of these metabolites by the disappearance of
the methyl group signal of C-8 or C-5 resonating at 61.2 and
60.4 ppm for xanthotoxin (3)13 and bergapten (2)13 respec-
tively and appearance of new high downﬁeld signals at d
130.2 ppm and d 148.5 ppm for metabolites (6) and (5), respec-
tively, which represented a hydroxylated carbon. The nature of
those metabolites was further conﬁrmed with previously
reported data.9 They displayed a molecular ion peak at m/z
201 in negative ESI mass spectral [M-1]+, and melting point
values at 243–244 C and 202 C for metabolites (6) and (5),
respectively. Thus, these two metabolites were identiﬁed as
xanthotoxol (6) and bergaptol (5), respectively.
The metabolite isolated from imperatorin (4)13 was identical
to xanthotoxol (6), when examined by TLCmethod on silica gel
G plates, using solvent system V and spraying with 10% sulfu-
ric acid followed by heating at 110 C for 10 min.13 The PESI of
the metabolites isolated from xanthotoxin (3)13 and imperato-
rin (4)13 showed the same pseudo molecular ion at m/z 201
which is consistent with data reported for xanthotoxol.9
In addition to the production of phenolic derivatives
metabolite, C. elegans was able to ferment xanthotoxin (3)13
into another metabolite (7). Examination of 1H NMR and
13C NMR signals of this metabolite (see experimental) revealed
that it is distinguishable from those of reference sample of xan-
thotoxin13 by the disappearance of oleﬁnic proton doublet sig-
nals resonating at dH 6.35, 7.75 ppm (J= 9.5) of H-3 & H-4.
Two shielded triplet proton signals resonating at dH 2.75 and
3.04 (J= 8.4), respectively can be observed in the metabolite
(7) spectrum. Each of these signals is integrated for two pro-
tons. Furthermore, the oleﬁnic carbon signals at dC 114.8,
144.4 of C-3 and C-4 of xanthotoxin (3)13 are replaced by
two saturated carbon signals at dC 25.9, 34.2, respectively,
supporting the reduction reaction and the downﬁeld shift of
C-2 carbonyl from dC 160.7 to 179.7 indicated the reduction
(hydrogenation) of C3–C4 double bond.
Upon comparison of IR spectrum of this metabolite with
that ofxanthotoxin,14 it showed no bands below 3000 cm1
for vinyl C–H stretching vibration and an aliphatic CH stretch-
ing vibration at >3000 cm1. On the other hand, the band at
1575 cm1 corresponding to conjugated enone is no longerobserved. These ﬁndings support the reduction of C3–C4 bond
(see experimental). Negative mode ESIMS showed a pseudo
molecular ion at m/z 217 and melting point values at 109–
110 C provide conclusive evidences of this reduction reaction.
This metabolite was identiﬁed as 3,4-dihydroxanthotoxin.
In the present study, C. elegans was able to metabolize the
investigated Furanocoumarins as xauthotoxin,13 bergapten13
and imperatorine13 into corresponding phenolic derivatives
via, dealkylation reaction, which is a very common reaction
in C. elegans xenobiotic metabolism.15 It is speciﬁc for these
types of coumarins yet it has a broad substrate speciﬁcation.
Reduction reaction takes place for xanthotoxin resulting in
the formation of dihydroderivatives, while bergapten and
imperatorin need further investigation. However, a hydroxyl-
ation reaction takes place for psoralen11 resulting in the forma-
tion of bergaptol.
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